6 Patents
- US124471782025Method of Treatment Using Anti-cd19 Rituximab-resistant Chimeric Antigen Receptors
Allogene Therapeutics, Inc.
0 cites - 0 cites
- 0 cites
- US118966172024Polynucleotides Encoding Rituximab-resistant Chimeric Antigen Receptors
ALLOGENE THERAPEUTICS, Inc.
0 cites - 0 cites
- 0 cites